Turning Point Therapeutics, Inc.

Historical 13F Holders

Symbol
TPTX
CUSIP
90041T108
All holders as of
Q2 2022
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q2 228 43.8 M $3.29 B
2022 Q1 162 46.0 M $1.24 B
2021 Q4 183 45.2 M $2.15 B
2021 Q3 197 44.9 M $2.99 B
2021 Q2 200 46.1 M $3.59 B
2021 Q1 212 44.4 M $4.21 B
2020 Q4 209 43.7 M $5.32 B
2020 Q3 177 39.5 M $3.45 B
2020 Q2 164 37.4 M $2.41 B
2020 Q1 126 29.9 M $1.34 B
2019 Q4 125 28.6 M $1.78 B
2019 Q3 105 24.2 M $911 M
2019 Q2 71 18.2 M $742 M
2019 Q1 1 4.00 $0